Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2016: 1.000
Source Normalized Impact per Paper (SNIP) 2016: 1.112

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 43, Issue 6 (Jun 2005)

Issues

Time course of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in patients presenting with acute coronary syndrome

Thomas Bertsch
  • Institute of Clinical Chemistry and Laboratory Medicine, Clinic Nuremberg, Nuremberg, Germany
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Tim Sueselbeck
  • First Department of Medicine, Faculty of Clinical Medicine Mannheim, University of Heidelberg, Mannheim Germany
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Christian Wolpert
  • First Department of Medicine, Faculty of Clinical Medicine Mannheim, University of Heidelberg, Mannheim Germany
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Ursula Hoffmann
  • First Department of Medicine, Faculty of Clinical Medicine Mannheim, University of Heidelberg, Mannheim Germany
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Jens J. Kaden
  • First Department of Medicine, Faculty of Clinical Medicine Mannheim, University of Heidelberg, Mannheim Germany
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Karl K. Haase
  • First Department of Medicine, Faculty of Clinical Medicine Mannheim, University of Heidelberg, Mannheim Germany
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Martin Borggrefe
  • First Department of Medicine, Faculty of Clinical Medicine Mannheim, University of Heidelberg, Mannheim Germany
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Martina Brueckmann
  • First Department of Medicine, Faculty of Clinical Medicine Mannheim, University of Heidelberg, Mannheim Germany
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2014-06-11 | DOI: https://doi.org/10.1515/CCLM.2005.113

References

  • 1

    Shah PK. New insights into the pathogenesis and prevention of acute coronary syndromes. Am J Cardiol 1997; 79: 17–23. Google Scholar

  • 2

    Brueckmann M, Bertsch T, Lang S, Sueselbeck, Wolpert C, Kaden JJ, et al. Time course of systemic markers of inflammation in patients presenting with acute coronary syndromes. Clin Chem Lab Med 2004; 42: 1132–9. Google Scholar

  • 3

    Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994; 94: 2493–503. CrossrefGoogle Scholar

  • 4

    Etoh T, Joffs C, Deschamps AM, Davis J, Dowdy K, Hendrick J, et al. Myocardial and intestinal matrix metalloproteinase activity after acute myocardial infarction in pigs. Am J Physiol Heart Circ Physiol 2001; 281: H987–94. Google Scholar

  • 5

    Fujimoto N, Hosokawa N, Iwata K, Shinya T, Okada Y, Hayakawa T. A one-step sandwich enzyme immunoassay for inactive precursor and complexed forms of human matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase, gelatinase B) using monoclonal antibodies. Clin Chim Acta 1994; 231: 79–88. Google Scholar

  • 6

    Kai H, Ikeda H, Yasukawa H, Kai M, Seki Y, Kuwahara F, et al. Peripheral blood levels of matrix metalloproteinase-2 and -9 are elevated in patients with acutecoronary syndromes. J Am Coll Cardiol 1998; 32: 368–72. CrossrefGoogle Scholar

  • 7

    Nomoto K, Oguchi S, Watanabe I, Kushiro T, Kanmatsuse K. Involvement of inflammation in acute coronary syndromes assessed by levels of high-sensitivity C-reactive protein, matrix metalloproteinase-9 and soluble vascular-cell adhesion molecule-1. J Cardiol 2003; 42: 201–6. Google Scholar

  • 8

    Inokubo Y, Hanada H, Ishizaka H, Fukushi T, Kamada T, Okumura K. Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndromes. Am Heart J 2001; 141: 211–7. Google Scholar

  • 9

    Zouridakis E, Avanzas P, Arroyo-Espliguero R, Fredericks S, Kaski JC. Markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris. Circulation 2004; 110: 1747–53. Google Scholar

  • 10

    Sato T, Ito A, Mori Y. Interleukin-6 enhances the production of tissue inhibitor of metalloproteinases (TIMP) but not that of matrix metalloproteinases by human fibroblasts. Biochem Biophys Res Commun 1990; 170: 824–9. Google Scholar

  • 11

    Kossakowska AE, Edwards DR, Prusinkiewicz C, Zhang MC, Guo D, Urbanski SJ, et al. Interleukin-6 regulation of matrix metalloproteinase (MMP-2 and MMP-9) and tissue inhibitor of metalloproteinase (TIMP-1) expression in malignant non-Hodgkin's lymphomas. Blood 1999; 94: 2080–9. Google Scholar

  • 12

    Pitt B. Potential role of angiotensin converting enzyme inhibitors in the treatment of atherosclerosis. Eur Heart J 1995; 16(Suppl. K): 49–54. CrossrefGoogle Scholar

  • 13

    Schieffer B, Bunte C, Witte J, Hoeper K, Boger RH, Schwedhelm E, et al. Comparative effects of AT1-antagonism and angiotensin-converting enzyme inhibition on markers of inflammation and platelet aggregation in patients with coronary artery disease. J Am Coll Cardiol 2004; 44: 362–8. Google Scholar

About the article

Corresponding author: Thomas Bertsch, MD, Institute of Clinical Chemistry and Laboratory Medicine, Clinic Nuremberg, Prof.-Ernst-Nathan-Strasse 1, 90419 Nuremberg, Germany Fax: +49-911-398-2710,


Published Online: 2014-06-11

Published in Print: 2005-06-01


Citation Information: Clinical Chemistry and Laboratory Medicine (CCLM), ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2005.113.

Export Citation

© Walter de Gruyter Berlin New York. Copyright Clearance Center

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Thorolf Brosche, Martina Brueckmann, Karl Konstantin Haase, Cornel Sieber, and Thomas Bertsch
Clinical Chemical Laboratory Medicine, 2007, Volume 45, Number 5
[2]
Grace Chung and Albert J Sinusas
Current Cardiology Reports, 2007, Volume 9, Number 2, Page 136

Comments (0)

Please log in or register to comment.
Log in